Dihydropyrimidine dehydrogenase/Radiation induced focus/RPA phosphorylation/Camptothecin.
INTRODUCTION
DNA is the principal target for the biologic effects of radiation. DNA double-strand breaks (DSBs) are the most important lesions produced in chromosomes by radiation. 1) In DNA DSBs repair, at least two major repair mechanisms, homologous recombination (HR) and non-homologous end joining (NHEJ) have been reported. HR is accomplished by copying information from homologous sequences in the sister chromatid. The HR pathway involves numerous factors and proceeds via multiple steps. HR must occur during the late S phase and G2 phase, because it depneds on the existence of sister chromatids to provide repair templates. 2) Gimeracil (5-chloro-2, 4-dihydroxypyridine) is a competitive inhibitor of dihydropyrimidine dehydrogenase (DPYD), which degrades pyrimidine including 5-FU in the blood. We have previously demonstrated that Gimeracil partially inhibits the HR of DNA DSBs.
3) Gimeracil has a radiosensitizing effect and also enhances sensitivity to Camptothecin (CPT). 4) DPYD is the target protein for radiosensitization by Gimeracil and depletion of DPYD inhibits HR. 5) This observation leads to the concept that inhibitors of DPYD can enhance the efficacy of radiotherapy through partial suppression of HR-mediated DNA repair pathways.
In this report, we investigated the mechanisms of radiosensitization of DPYD inhibition by scoring the radiationinduced foci of various proteins involved in HR, and by examining replication protein A (RPA) phosphorylation after radiation. We also examined the effects of DPYD depletion on the sensitivity of CPT and focus formation induced by CPT.
MATERIALS AND METHODS

Cell and drug
DLD-1 is a human colorectal carcinoma cell line. DLD-1 was cultured in RPMI-1640 medium supplemented with 10% fetal calf serum at 37°C. CPT was obtained from Sigma Chemical Company.
siRNA transfections
Stealth RNA TM siRNA oligonucleotides for dihydropyrimidine dehydrogenase (DPYD) were purchased from Invitogen (Carlsbad, CA, USA). The sense sequence (5'→3') is UAUUGUAACUGCACAUAAUGCUAGC. DLD-1 cells were plated in antibiotic-free medium for 24 h prior to transfection. The DPYD siRNA or a scrambled siRNA control (Stealth RNA TM Negative Control Duplexes) was transfected using Lipofectamine RNAiMAX (Invitrogen) according to the manufacturer's instructions. Forty eight h after transfection, fresh medium was added. Depletion of DPYD by siRNA was confirmed by Reverse-transcription PCR (RT-PCR).
Reverse-transcription PCR (RT-PCR)
Semiquantitative reverse transcription-PCR (RT-PCR) was carried out as previously described. 6) Briefly, total RNA was extracted using TRIzol (Invitrogen); after which, a 1 μg sample was reverse transcribed using SuperscriptIII (Invitrogen). The following primer pairs were used for RT-PCR: DPYD: F-TGACTTTCCAGACAACATTGTGAT and R-GCAAGTTCCGTCCAGTCATTTT and ACTB (actin-beta) F-ATTGCCGACAGGATGCAGA.
Radiation and camptothecin treatment
DLD-1 cells which were transfected with the DPYD siRNA received various doses of radiation or CPT treatments. Trypsinized cells were seeded for colony formation assay in 60 mm dishes at a day before radiation or adding CPT into the dishes. Cells were irradiated with 120 kV photons at a dose rate of 1.17 Gy/min. Ten nM of CPT was added to the cells for 6 h before radiation. Experiments were repeated 3 times. Average values and standard deviations were expressed. T-test was used to examine the significance.
Focus assay
Rabbit polyclonal antibodies against the following targets were used: NBS1 (Novus Biologicals, CO, USA), ATM (phospho-Ser 1981) (Novus Biologicals, CO, USA), ATRinteracting protein (ATRIP) (Abcam, Tokyo, Japan), and Rad51 (Oncogene, CA, USA). The mouse monoclonal antibody used was RPA/p34 (Sigma-Aldrich, MO, USA). The other immunostaining steps were identical to those described in the following section. Ionizing radiationinduced focus formation of various kinds of proteins involved in HR was measured. DPYD-depleted DLD-1 cells were treated with 4 Gy of radiation. Cells were applied on slide glass at 4 h after irradiation. Cells diluted to appropriate numbers were grown on a glass slide and fixed with cold methanol for 20 min, rinsed with cold acetone for 10 seconds, then air dried. The abovementioned antibodies to various kinds of proteins were used as the primary antibodies. Alexa-488-conjugated anti-rabbit or Alexa-546-conjugated anti-mouse IgG (Molecular Probes) were used for visualization of radiation-induced foci with the antibodies of various proteins. Slides were mounted using an antifade reagent (Mounting medium, DAKO). Foci were observed using an Olympus fluorescent microscope under 10/100 oil immersion. We analyzed cells with RPA foci: the foci number was quantified only in G2 cells since RPA foci were not observed in the G1 phase or S phase. For quantification of NBS1, RPA, Rad51, ATM, or ATRIP foci, clear and easily distinguished dots of certain brightness were counted as positive foci. The number of foci was counted in 100 cells at each time point by direct observation and the average number of foci per cell was calculated. For quantification of colocalized foci, cells that had 10 or more colocalized foci were defined as positive and the ratio of positive cells was calculated. In analysis of foci induced by CPT, we used the percentage of positive cells since 100 nM of CPT produced many foci and an accurate count of foci was not possible. Cells that had more than 10 foci were treated as positive.
Western blot analysis
Cells were lysed by sonication in 250 μl of ice-cold RIPA buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM EDTA, Complete TM protease-inhibitor mixture [Roche] and phosphatase inhibitor cocktail II [Sigma] ) and then boiled in SDS sample buffer. Cell lysates were separated by SDS/ PAGE and transferred to a PVDF membrane (Bio-Rad). The membrane was blocked with TBS (Tris Buffered Saline)-T (Tween 20) containing 5% bovine serum albumin (Sigma) or 5% nonfat dry milk, and incubated with primary antibody diluted in Can Get Signal buffer (Toyobo). The immunoreactive bands were visualized using the horseradish peroxidase-conjugated anti-rabbit IgG antibody (Jackson ImmunoResearch Laboratories) and ECL Western blotting detection system (GE Healthcare Bio-Sciences). Mouse monoclonal antibody against RPA/p34 (Sigma, Saint Louis, USA) was used for the detection of RPA, and rabbit polyclonal antibody against Phospho RPA34 Ser4/Ser8 (Bethyl Laboratories, TX, USA) was used for the detection of phosphorylated RPA. We used Image J 1.39 (free NIH software) to analyze the results of immunoblotting.
RESULTS
Radiation-induced foci
RT-PCR demonstrated that the expression of DPYD was suppressed down to 15% of control cells by specific siRNA transfection. In order to elucidate the mechanism of radiosensitization by DPYD depletion, we awarded a score to the foci of various proteins involved in HR (Fig. 1a) . When cells were not irradiated, there were no differences in NBS1, RPA, and Rad51 foci between DPYD-depleted cells and cells transfected with a scrambled siRNA (SC siRNA cells) (Fig. 1b) . When cells were irradiated, a time dependent change in focus formation in NBS1, RPA, and Rad51 was seen in the DPYD-depleted cells and SC siRNA cells. Induction of Rad51 foci tended to be larger at 2.5 h after radiation than at 4 h. In contrast, the induction of NBS1 foci tended to be larger at 4 h after radiation than at 2.5 h. A dose-dependent change in focus formation in NBS1, RPA, and Rad51 was also seen in the DPYD-depleted cells and SC siRNA cells. The induction of NBS1, RPA, and Rad51 foci irradiated with 8 Gy was significantly larger than that with 4 Gy at 4 h after radiation (p < 0.05).
When cells were irradiated, the numbers of foci of NBS1 in the DPYD-depleted cells were significantly larger than the SC siRNA cells at 2.5 h or 4 h after radiation (p < 0.01) (Fig. 1b) . On the contrary, the numbers of RPA and Rad51 foci in DPYD-depleted cells were significantly smaller than the cells transfected with SC siRNA cells at 2.5 h or 4 h after radiation (p < 0.01). There was no difference in the size and distribution of NBS1, RPA, and Rad51 foci between the DPYD-depleted cells and SC siRNA cells.
Double immunostaining was performed using antibodies against NBS1 and RPA to examine the colocalization of NBS1 and RPA foci. Colocalization is indicated by yellow foci (Fig. 1a) . Without radiation, colocalization of NBS1 and RPA foci was seen in less than 1% of the SC siRNA cells and DPYD-depleted cells. When the cells were irradiated, colocalization of NBS1 and RPA foci in the SC siRNA cells significantly increased from 2.5 to 4 h after radiation (p < 0.01). The colocalization of NBS1 and RPA foci in the DPYD-depleted cells was significantly less than in the SC siRNA cells at 2.5 h or 4 h after radiation (p < 0.01) (Fig.  1c) . In order to provide further insight, the ratio of colocalized foci in each cell is shown in Fig. 1d . A similar tendency to that shown in Fig. 1c was found. The colocalization of NBS1 and RPA foci in DPYD-depleted cells was significantly less than in the SC siRNA cells at 4 h after radiation (p < 0.01).
The colocalization of NBS1 and Rad51 foci and that of Rad51 and RPA foci were also examined (Fig. 1e) . Both colocalized foci were seen in only 5% or less of the SC siRNA cells and DPYD-depleted cells. Even in cells that had colocalized foci, the ratio of colocalized foci to all foci was less than 10%. There were no significant differences between SC siRNA cells and DPYD-depleted cells in both colocalizations although accurate analysis is difficult due to the small numbers of colocalized foci.
There were no differences in ATM or ATRIP foci between the SC siRNA and DPYD-depleted cells (Fig. 1f) .
Phosphorylation of RPA
We performed an examination to determine whether DPYD depletion influenced the radiation-induced phosphorylation of RPA (Fig. 2a) . CPT treatment was used as a positive control for phosphorylation of RPA. In immunoblotting using the RPA/p34 antibody, a higher molecular weight form of RPA/p34 (p36) accumulated during CPT treatment. Phosphorylation of the p34 subunit of RPA resulted in a 2 kDa increase in size. 7) However, a higher molecular weight form of RPA/p34 (p36) was not clear in cells treated with radiation. Thus, we used an antibody to phosphorylated RPA34 Ser4/Ser8 to investigate the phosphorylation of RPA. The phosphorylation of RPA by irradiation was partially suppressed in DPYD-depleted cells compared with the control (Fig. 2b) . The measurement of RPA immunoblotting showed that the reduction rate of the radiation-induced phosphorylation of RPA in DPYD-depleted cells was 30% compared with the control cells.
Radiosensitization by DPYD depletion and CPT
The DPYD-depleted DLD-1 cells were significantly more sensitive to radiation than the control cells (p = 0.033, Fig.  3a) , indicating that DPYD depletion has a radiosensitizing effect. The DPYD-depleted cells treated with CPT had a significantly lower survival fraction at 0 Gy than the control cells treated with CPT (p = 0.049), indicating that DPYD depletion enhances sensitivity to CPT. However, DPYD depletion did not decrease the plating efficiency of the DLD-1 cells. Figure 3a also demonstrated that DPYD depletion plus CPT had a much greater cell-killing effect than radiation alone (cells without DPYD depletion and CPT).
CPT has a cell-killing effect. In order to analyze the radiosensitizing effect of DPYD depletion plus CPT, we modified Fig. 3a by correcting the survival fraction of CPT at 0 Gy to 1 (Fig. 3b) . SC siRNA cells (cells transfected with a scrambled siRNA) treated with CPT had a significantly lower survival fraction than SC siRNA without CPT (p = 0.008), indicating that CPT enhances radiosensitivity. Figure  3b also suggests that the radiosensitizing effect of DPYD depletion plus CPT has the additive effect of radiosensitization by DPYD depletion and CPT.
Foci induced by CPT in DPYD-depleted cells
In order to investigate the mechanism of sensitization of CPT effect by DPYD depletion, we scored the foci of NBS1 and RPA in cells treated with CPT (Fig. 3c) . The percentage of positive cells of NBS1, RPA, or colocalization of NBS1 and RPA foci was not significantly different between the DPYDdepleted cells and SC siRNA cells (Fig. 3d) . Furthermore, there was no difference in the size and distribution of these foci between the DPYD-depleted cells and SC siRNA cells.
DISCUSSION
After the induction of DNA damage, many proteins associated with DNA damage signaling, DNA repair, and cell cycle checkpoints become localized to the sites of damage and form nuclear "foci". 8) We would expect the number of foci to inversely correlate with time, since repair proteins would no longer be needed at the sites where the DSBs have been repaired. 9) In order to gain insight into the molecular mechanism of the partial inhibition of HR by DPYD depletion, we analyzed the radiation-induced foci of various proteins involved in HR (Fig. 1) .
NBS1 foci increased from 2.5 hr to 4 hr after 4 Gy (Fig.  1b) . NBS1 foci may represent all DNA DSBs since Mre11/ Rad50/NBS1 complex works in HR and NHEJ. 10 ) HR repairs only a small part of the total DSBs arising in G2 in human cells.
11) Therefore, NBS1 foci will decrease timedependently after irradiation, even if steps of HR before RPA are retarded because most DSBs are repaired by NHEJ, competing with our results. For quantification of foci, we counted clear and easily distinguished dots of certain brightness as positive foci. NBS1 foci at 4 h after radiation were larger and more vivid than at 2.5 h, which might influence the identification and calculation of NBS1 foci.
DPYD depletion by siRNA significantly restrained the formation of the radiation-induced foci of Rad51 and RPA, whereas it increased the number of foci of NBS1 (Fig. 1b) . The numbers of colocalization of NBS1 and RPA foci in DPYD-depleted cells after radiation were significantly smaller than in the control cells (Fig. 1c) . The initial step in HR is DSB end resection in order to generate a 3' overhang. This DSB end modification can be enzymatically processed by the Mre11/Rad50/NBS1 (MRN) complex. In the next step, RPA binds to the 3' overhang to protect DNA ends from further resection. RPA is then replaced by Rad51. 2) This decrease in foci formation of RPA in our results is attributable to the decreased single-stranded DNA that is generated by the MRN complex-dependent resection of DNA DSB ends. NBS1 is recruited to DNA DSB sites before RPA binds to the generated 3'-overhang whereas Rad51 is recruited after RPA binding. Proteins recruited to DNA DSB sites before RPA binding can accumulate and make unchanged or increased numbers of foci because the steps of HR before RPA are retarded. The foci of RPA and Rad51 may decrease because RPA or Rad51 cannot be recruited to DNA DSB sites.
Recently, Nakamura et al. demonstrated that the complex formation of NBS1 and RNF20 might facilitate the chromatin reorganization and generation of nucleosome-free singlestrand DNA regions, which is crucial for Rad51-mediated HR. 12) In fact, DNA damage-induced foci of Rad51 were not formed in conditional NBS1 null mouse cells. 13) In this way, the MRN complex generates the resection of DNA DSB ends. Since a focus assay indicates that the inhibition of DPYD inhibits the process between NBS1 and Rad51, the inhibition of DPYD could decrease the efficiency of DSB end resection.
DPYD is known to be an enzyme that is involved in pyrimidine degradation. The assay of pyrimidine degradation is performed by measuring the 5-FU-degrading activity. The DLD-1 cells had little DPYD protein, and no 5-FUdegrading activity of DLD-1 was detected.
14) Therefore, it is unlikely that perturbation of pyrimidine catabolism by inhibition of DPYD is related to the inhibition of HR. DPYD may act in HR with a mechanism other than pyrimidine degradation. The results of our focus assays indicate that DPYD may be involved in DSB end resection.
Ionizing irradiation and treatment with DNA-damaging chemicals such as CPT stimulate RPA phosphorylation by ATM, ATR, and DNA-PK. 15) Hyperphosphorylation of RPA down-regulates DNA replication in vivo. RPA hyperphosphorylation mimetic mutants transiently expressed in human cells were unable to associate with replication centers. This effect was dependent on the presence of multiple negative charges in the phosphorylation domain of RPA32. The phosphorylation mimetic forms of RPA associated with repair foci after treatment with CPT or hydroxyurea. 16) These observations indicate that RPA32 phosphorylation greatly reduces RPA association with replication centers, and probably shifts the pool of cellular RPA to DNA repair reactions, facilitating HR.
17) Therefore, we examined whether DPYD depletion influences the phosphorylation of RPA. The phosphorylation of RPA by irradiation was partially suppressed in the DPYD-depleted cells (Figs. 2a and b) . These results suggest that DPYD depletion might partially inhibit DNA repair with HR by suppressing the phosphorylation of RPA.
We also examined whether the number of ATM (ataxia telangiectasia mutated) or ATR-interacting protein (ATRIP) foci changed by treatment with DPYD depletion (Fig. 1f) . ATR and ATRIP both localize to intranuclear foci after DNA damage. 18) ATRIP and ATR are mutually dependent partners in cell cycle checkpoint signaling pathways. In our results, ATM or ATRIR foci did not change by DPYD depletion, indicating that DPYD depletion may have no affect on the localization of ATM or ATRIR to sites of DNA DSBs. The molecular mechanism of suppression of RPA phosphorylation in DPYD-depleted cells is still unknown.
We previously demonstrated that Gimeracil, a competitive inhibitor of DPYD, enhanced the sensitivity of CPT. 4) Accordingly, we examined whether DPYD deletion enhanced the cell-killing effects of CPT. We also investigated the radiosensitizing effect of the combined use of DPYD deletion and CPT. Figure 3a demonstrates that DPYD depletion had a radiosensitizing effect as well as enhanced sensitivity to CPT. The results of foci of NBS1 and RPA (Figs. 3c and d) suggest that the mechanism of CPT sensitization effect by DPYD depletion may differ from that of radiosensitization. However, caution is required when interpretating the data presented in Fig. 3d . We analyzed NBS1 foci and RPA foci in G2 cells both in a radiation experiment (Fig. 1b) and CPT experiment (Fig. 3d) , because RPA foci cannot be observed or analyzed in the G1 phase or S phase, respectively. CPT induces DSBs preferentially in the S phase, because it is a topoisomerase I inhibitor. Therefore, we may have analyzed NBS1 foci or RPA foci in G2 cells whose DSBs induced by CPT had been repaired in the S phase. Figure 3b demonstrated that the radiosensitizing effect of DPYD depletion plus CPT was the additive effect of radiosensitization by DPYD depletion and CPT. DPYD depletion did not decrease the plating efficiencies of the DLD-1 cells, suggesting that DPYD depletion may not be so toxic. This result corresponds to Gimeracil, an inhibitor of DPYD that has a low toxicity. 19) Considering these results, the combination of CPT and drugs that inhibit DPYD may prove useful for radiotherapy as a method of radiosensitization.
In summary, DPYD depletion by siRNA significantly restrained the formation of radiation-induced foci of Rad51 and RPA, whereas it increased the number of foci of NBS1. The numbers of colocalization of NBS1 and RPA foci in DPYD-depleted cells after radiation were significantly smaller than in the control cells. These results indicate that DPYD depletion may affect the efficiency of DNA resection to generate a 3' overhang in HR. The phosphorylation of RPA by irradiation was partially suppressed in the DPYDdepleted cells, contributing to partial inhibition of DNA repair by HR. DPYD depletion had a radiosensitizing effect as well as enhanced sensitivity to CPT. Thus, the combination of CPT and drugs that inhibit DPYD may prove useful for radiotherapy as a method of radiosensitization.
